Schrödinger, Inc. (NASDAQ:SDGR) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Schrödinger, Inc. (NASDAQ:SDGRGet Free Report) have been given a consensus recommendation of “Moderate Buy” by the nine brokerages that are presently covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $42.80.

A number of equities research analysts have issued reports on the company. Citigroup cut their price target on Schrödinger from $39.00 to $37.00 and set a “buy” rating for the company in a research note on Thursday, May 2nd. The Goldman Sachs Group cut their price target on Schrödinger from $29.00 to $26.00 and set a “neutral” rating for the company in a research note on Friday, March 1st. Piper Sandler dropped their price objective on shares of Schrödinger from $60.00 to $50.00 and set an “overweight” rating for the company in a report on Thursday, February 29th. KeyCorp dropped their price objective on shares of Schrödinger from $38.00 to $33.00 and set an “overweight” rating for the company in a report on Thursday, February 29th. Finally, Bank of America dropped their price objective on shares of Schrödinger from $38.00 to $32.00 and set a “neutral” rating for the company in a report on Thursday, February 29th.

Get Our Latest Stock Report on SDGR

Schrödinger Price Performance

NASDAQ:SDGR opened at $21.78 on Friday. The firm has a market capitalization of $1.58 billion, a price-to-earnings ratio of -11.59 and a beta of 1.58. Schrödinger has a one year low of $20.76 and a one year high of $59.24. The business has a fifty day moving average price of $24.42 and a 200-day moving average price of $28.02.

Schrödinger (NASDAQ:SDGRGet Free Report) last posted its quarterly earnings data on Wednesday, May 1st. The company reported ($0.76) EPS for the quarter, hitting the consensus estimate of ($0.76). The firm had revenue of $36.60 million during the quarter, compared to analyst estimates of $41.23 million. Schrödinger had a negative return on equity of 29.25% and a negative net margin of 75.94%. On average, equities research analysts expect that Schrödinger will post -2.7 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Spire Wealth Management lifted its stake in Schrödinger by 66.7% in the third quarter. Spire Wealth Management now owns 1,000 shares of the company’s stock worth $28,000 after purchasing an additional 400 shares during the last quarter. International Assets Investment Management LLC grew its holdings in shares of Schrödinger by 3,480.0% in the fourth quarter. International Assets Investment Management LLC now owns 1,790 shares of the company’s stock worth $64,000 after purchasing an additional 1,740 shares during the last quarter. GAMMA Investing LLC bought a new position in shares of Schrödinger in the fourth quarter worth about $67,000. PNC Financial Services Group Inc. grew its holdings in shares of Schrödinger by 186.7% in the fourth quarter. PNC Financial Services Group Inc. now owns 2,127 shares of the company’s stock worth $76,000 after purchasing an additional 1,385 shares during the last quarter. Finally, Exchange Traded Concepts LLC grew its holdings in shares of Schrödinger by 34.0% in the fourth quarter. Exchange Traded Concepts LLC now owns 4,244 shares of the company’s stock worth $152,000 after purchasing an additional 1,076 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Schrödinger Company Profile

(Get Free Report

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.

See Also

Analyst Recommendations for Schrödinger (NASDAQ:SDGR)

Receive News & Ratings for Schrödinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrödinger and related companies with MarketBeat.com's FREE daily email newsletter.